Long COVID plays role in severe and selective neuropsychological impairments

Article

Self-reported survey data “showed that a majority reported reductions in visual recognition and navigation abilities,” the researchers reported.

Image Credit: © Khunatorn - stock.adobe.com

Survey data that was self-reported by 54 individuals who responded to the survey “showed that a majority reported reductions in visual recognition and navigation abilities,” the researchers reported. (Image credit: Adobe Stock/Khunatorn)

Marie-LuiseKieseler and Brad Duchaine, PhD students from Dartmouth College, Hanover, NH, reported that COVID-19 can cause severe and selective neuropsychological impairments after long COVID.1 These impairments can be life-altering and persistent.

They described the case of a 28-year-old woman, Annie, who had normal face recognition, ie, prosopagnosia, before she developed COVID-19 in March 2020. Two months later, she noticed that she was having difficulties recognizing faces when her COVID-19 symptoms relapsed. The problems with face recognition have persisted.

Kieseler and Duchaine assessed Annie’s abilities to recognize faces using 4 tests: a famous faces test and a Doppelganger test to assess her long-term face identity recognition abilities, and 2 tests of unfamiliar face identity recognition; her navigational skills were also markedly impaired after she developed COVID-19. They reported that she performed poorly on all 4 tests. However, she performed normally on tests of face detection, face identity perception, object recognition, scene recognition, and non-visual memory.

Survey data that was self-reported by 54 individuals who responded to the survey “showed that a majority reported reductions in visual recognition and navigation abilities,” the researchers reported.

In Annie’s case, she resumed working from home in April 2020. However, she could not recognize her father when she saw him again after she recovered from her illness and she could not differentiate him from her uncle.

“My dad’s voice came out of a stranger’s face,” she said.

She also reported that she experienced problems getting around a grocery store and identifying her car in the lot.

The researchers summarized, “Annie's results indicate that COVID-19 can produce severe and selective neuropsychological impairment similar to deficits seen following brain damage, and it appears that high-level visual impairments are not uncommon in people with long COVID."

Reference
1. Kieseler M-L, Duchaine B. Persistent prosopagnosia following COVID-19. Cortex. 2023; Published online March 9, 2023; https://doi.org/10.1016/j.cortex.2023.01.012Get rights and content
Recent Videos
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
© 2025 MJH Life Sciences

All rights reserved.